Re: What's Next?
in response to
by
...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Message: Re: What's Next?
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
SanFrancisco99
Below is an earlier post I made summarizing various catalysts that could propel this stock which has been refined and added to by many on this board. IMHO we will be in a wait and hold period for 6 to 12 months. One high priority that must be resolved quite soon is the financing of the Zenith trial and operations which could spawn a regional partnership or bring in a new player. I agree with your post and also hope that Resverlogix will announce an orphan trial and possibly other promising compound(s) in the next 6-12 months. If RVX is what they sez it is and we all believe it to be, then BP will step in, but not until they have proof of concept or FDA approval. The Hepa deal and $46MM cash infusion at a substantial premium to market is a strong indication that RVX-208 is a viable and marketable therapy - I'm not sure if I would still be holding RVX if it weren't for the life saving Hepa deal.
A Critical Mass
in response to Zenith AGM is come and gone... by kelsee
posted on Jan 09, 16 09:09PM Use the IP Check tool [?]
One day in the not too distant future these two epigenetic pioneers will reach the state of critical mass and explode. It may be 6, 12, 18, 24 months away - we must be patient - it's coming and it's going to be big. Several catalysts are out there and any could start the reaction.
RVX-208 BetonMace Trial approved by FDA
RVX partners with BP
RVX acquired by BP
BetonMace trial successfully reaches endpoints
RVX Nasdaq listing
RVX upgraded to Strong Buy
RVX receives major institutional coverage
Resverlogix commences Phase 1 trial for promising new Alzheimers treatment
Resverlogix begins new trial on orphan indication
Zenith acquires Nasdaq listing
Zenith lists on TSX
ZEN-3694 success
Zenith announces new trial for treatment of breast cancer
RVX holds RVX-208 and about 2500 other compounds
ZEL holds ZEN-3694 and 1500 other compounds
To hold this 'diamond in the rough' at this point in time and at this price is an unbelievable opportunity - Hallelujah!
Chicagoest
6 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply